The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma.
 
Scott Moerdler
Patents, Royalties, Other Intellectual Property - Scientific knowledge patent pending related to HHLA2
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Sheena Tenney
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Alice L. Yu
Leadership - OPKO Health
Stock and Other Ownership Interests - OPKO Health/GeneDx
Honoraria - EUSA Pharma
Consulting or Advisory Role - OBI Pharma
Speakers' Bureau - EUSA Pharma
Research Funding - United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - cancer targeting peptides; Globo H-Diphtheria toxoid vaccine for cancer therapy; Methods for suppressing cancer by inhibition of TMCC3; NKT stimulatory phenyl-glycolipids for cancer therapy and vaccine adjuvant
Travel, Accommodations, Expenses - EUSA Pharma
 
Wendy B. London
Consulting or Advisory Role - Jubilant Radiopharma; Merck
Research Funding - Agios; Aileron Therapeutics; Bluebird Bio; Bristol-Myers Squibb; Novartis